CAM
GSK icon

Cozad Asset Management’s GSK GSK Stock Holding History

Cozad Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,589
Closed -$269K – 406
2024
Q3 		$269K Sell
6,589
-18
-0.3% -$736 0.03% 343
2024
Q2 		$254K Sell
6,607
-372
-5% -$15.6K 0.03% 340
2024
Q1 		$299K Sell
6,979
-2,304
-25% -$95K 0.03% 321
2023
Q4 		$344K Sell
9,283
-738
-7% -$26.5K 0.04% 297
2023
Q3 		$363K Buy
10,021
+802
+9% +$28.5K 0.05% 276
2023
Q2 		$329K Hold
9,219
– – 0.04% 289
2023
Q1 		$328K Sell
9,219
-400
-4% -$14K 0.04% 285
2022
Q4 		$338K Buy
9,619
+1,280
+15% +$42.6K 0.05% 280
2022
Q3 		$245K Sell
8,339
-697
-8% -$26.4K 0.04% 302
2022
Q2 		$492K Buy
9,036
+1,800
+25% +$99.4K 0.08% 220
2022
Q1 		$394K Hold
7,236
– – 0.06% 258
2021
Q4 		$399K Buy
7,236
+108
+2% +$5.62K 0.06% 248
2021
Q3 		$340K Sell
7,128
-404
-5% -$20.3K 0.05% 259
2021
Q2 		$375K Sell
7,532
-432
-5% -$20.8K 0.06% 248
2021
Q1 		$355K Sell
7,964
-872
-10% -$39.6K 0.06% 253
2020
Q4 		$406K Sell
8,836
-178
-2% -$8.18K 0.07% 221
2020
Q3 		$424K Sell
9,014
-352
-4% -$17.6K 0.08% 211
2020
Q2 		$478K Sell
9,366
-1,272
-12% -$65.3K 0.1% 192
2020
Q1 		$504K Sell
10,638
-1,052
-9% -$56.1K 0.17% 126
2019
Q4 		$687K Buy
11,690
+136
+1% +$7.57K 0.18% 125
2019
Q3 		$616K Sell
11,554
-336
-3% -$17.3K 0.18% 125
2019
Q2 		$595K Buy
11,890
+144
+1% +$7.23K 0.17% 127
2019
Q1 		$614K Sell
11,746
-888
-7% -$44.4K 0.19% 130
2018
Q4 		$603K Buy
12,634
+285
+2% +$14K 0.21% 122
2018
Q3 		$620K Buy
12,349
+456
+4% +$23.2K 0.18% 123
2018
Q2 		$599K Buy
+11,893
New +$599K 0.19% 126

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cozad Asset Management's GSK Position: Q4 2024 in Review

Cozad Asset Management sold out of GSK (GSK) in Q4 2024, closing a stake of 6,589 shares — an estimated $269K sold.

Cozad Asset Management first reported a position in GSK in Q2 2018 and held it in 26 quarters. The position peaked at $687K in Q4 2019. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Cozad Asset Management reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Cozad Asset Management sold 6,589 GSK shares in Q4 2024, an estimated $269K.
  • Cozad Asset Management first reported a position in GSK in Q2 2018 and held it in 26 quarters.
  • Cozad Asset Management's GSK position peaked at $687K in Q4 2019.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Cozad Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.